Mark Fawcett - 25 Feb 2021 Form 4 Insider Report for Clinigence Holdings, Inc. (NUTX)

Role
Director
Signature
Mark Fawcett
Issuer symbol
NUTX
Transactions as of
25 Feb 2021
Net transactions value
+$571,255
Form type
4
Filing time
21 Dec 2021, 12:26:48 UTC
Next filing
24 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NUTX Common Stock Other $547,257 +268,263 +2982% $2.04* 277,259 28 Jan 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NUTX Director Stock Option (right to buy) Purchase +85,120 85,120 05 Aug 2020 Common Stock 85,120 Direct F2
transaction NUTX Warrants to Puchase common stock Purchase $23,999 +3,598 $6.67* 3,598 21 Mar 2019 Common Stock 3,598 $6.67 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Acquired as per Merger Transaction exchange
F2 10,120 shares at $5.56/share exercise date 8/5/2020 expiration date 8/5/2029 45,000 shares at $1.50/share exercise date 1/27/2020 expiration date 1/27/2027 30,000 shares at $1.50/share exercise date 5/11/2020 expiration date 12/31/2024